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Objectives: To examine the diameter and distensibility of the abdominal aorta in patients with severe a~-antitrypsin 
deficiency, and to compare the results with those of normal subjects. 
Material and methods: Abdominal aortic diameter and stiffness (fi) was measured using echo-tracking sonography in 
19 men (mean age 50, range 25-79) and 17 women (mean age 46, range 26-62) with severe ~2-antitrypsin deficiency. 
The results were compared with those of healthy individuals of corresponding age and gender. 
Results: There was no significant difference in the abdominal aortic diameter between controls and patients with ~- 
antitrypsin deficiency when corrected for age, sex and body surface area (men p = 0.20, women p = 0.10). Men with ~I- 
antitrypsin deficiency showed significantly lower stiffness in the abdominal aorta compared to controls (p=0.025), 
whereas women did not (p =0.17). 
Conclusions: No significant difference in abdominal aortic diameter could be detected in patients with a~-antitrypsin 
deficiency compared with controls. However, aortic distensibility in men with ~-antitrypsin deficiency is altered. This 
may reflect early vessel wall abnormality. 
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Introduction 
The question has been raised as to whether there is a 
link between ~l-antitrypsin deficiency and aneurysmal 
disease. ~-Antitrypsin is a glycoprotein synthesised in
the liver and secreted into the bloodstream, where it is 
a major and effective protease inhibitor. Homozygous 
deficiency of otl-antitrypsin (PiZZ), which is auto- 
somally transmitted, has a relatively high prevalence in
northern Europe (in Sweden, 1/1600). 1'2 Smokers with 
homozygous ~l-antitrypsin deficiency (PiZZ) are 
known to be at high risk of developing emphysema 
because of excessive lastase activity, which causes de- 
struction of the lung parenchyma. 3 Patients with severe 
~l-antitrypsin deficiency are also known to have an in- 
creased risk for developing liver disease. 4 However, 
most patients who have heterozygous deficiency (about 
5-10% of Europeans carry the PiZ allele), and also sev- 
eral non-smokers with homozygous deficiency, never 
develop these manifestations and remain undiagnosed, 
despite decreased ~-antitrypsin. By inhibiting various 
proteolytic enzymes, e.g. elastase, ~l-antitrypsin the- 
oretically has an important role in maintaining the in- 
tegrity of connective tissue, including the blood vessel 
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wall. By disturbing the balance between protelytic en- 
zymes and their inhibitors, adeficiency of ~l-antitrypsin 
could result in degradation ofthe arterial wall, and sev- 
eral investigators have proposed that ~l-antitrypsin de- 
ficiency may be a pathogenetic factor in the 
development ofabdominal aortic aneurysms. 5'6
The aim of the present study was to examine the 
diameter of the abdominal aorta in patients with ~l- 
antitrypsin deficiency and to compare the results with 
those of normal subjects. As a more sensitive marker 
of the structural integrity of the aortic wall the dis- 
tensibility of the aorta, expressed as stiffness (p), was 
also measured to clarify whether patients with ~l- 
antitrypsin deficiency have any signs of defective ves- 
sel wall function. 
Material 
The patients were recruited from the Swedish register 
of ~l-antitrypsin deficiency. The studies were per- 
formed in 17 women (mean age 46, range 26-62) and 
19 men (mean age 50, range 25-79). Two other women 
and one man were also investigated, but were excluded 
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Table 1. Demographic and clinical data of patients with ~-anti- 
trypsin deficiency. All data, except frequencies, are presented as 
mean ± S.D. 
Women Men 
Number 17 19 
Age (years) 46 _+ 11 50 + 16 "~ 
Height (cm) 165 + 6 180 + 7 
Weight (kg) 65 _+ 13 77 + 15 
Body surface area (m R) 1.72 ± 0.2 1.96 + 0.2 "~ 
Systolic blood pressure (mmHg) 119 + 7 130 ± 11 
Diastolic blood pressure (mmHg) 78 ± 7 82 ± 8 
Mean arterial pressure (mmHg) 92 + 7 99 ± 8 
because they were hypertensive at the time of in- 
vestigation. All subjects but one had homozygous %- 
antitrypsin deficiency (PiZZ phenotypes). One man 
had heterozygous deficiency (PiSZ). %-Antitrypsin 
phenotyping was carried out using isoelectric focus- 
ing / In  eight women and 10 men %-antitrypsin de- 
ficiency was diagnosed due to their lung disease. 
Of these, eight women and eight men were using 
bronchodilators, and three women and four men were 
also using inhaled steroids. The other nine women and 
nine men were free from symptoms and medication, 
except one woman using 6-blockers and one man and 
one woman using diuretics because of hypertension 
(these were all normotensive at the time of in- 
vestigation). In the asymptomatic patients %-anti- 
trypsin deficiency was diagnosed because they had 
close relatives with emphysema or liver disease due 
to severe ~-antitrypsin deficiency. Clinical details of 
the patients are given in Table 1. Two women and two 
men were smokers and seven women and nine men 
were ex-smokers. The ratio between ankle and brachial 
arterial pressure was >1 in all patients, indicating 
absence of obliterative atherosclerotic lesions in the 
arteries to the lower limbs. All patients gave informed 
consent according to the Helsinki declaration. 
To obtain age- and gender-matched reference values 
for abdominal aortic diameter and stiffness, a control 
group of 165 healthy, normotensive subjects (81 
women; age range 4-79, and 84 men; age range 4-74) 
was used. g'9 Of these, 33 women were in the age range 
25-65, and 47 men were in the age range 25-79, i.e. 
in the age range of the patients with %-antitrypsin 
deficiency. Detailed information concerning the control 
group has previously been publ ishedY None of the 
control subjects reported previous cardiopulmonary 
disease, diabetes or smoking, and all were free from 
current medication. The control subjects were ex- 
amined by the same staff as the patients with %- 
antitrypsin deficiency, and the studies of normal sub- 
jects and patients were overlapping in time. 
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Fig. 1. Original tracing of a diameter curve of the abdominal orta 
during a heart cycle in a 49-year old man with ~-antitrypsin 
deficiency. 
Methods 
Ultrasonic measurements of aortic diameter and 
distensibitilty 
Aortic diameter and pulsatile diameter changes were 
measured by means of echo-tracking sonography, 1°'11 
as described in the preceding article in this journal. 
The recording of the abdominal aorta was conducted 
distal to the renal arteries, approximately 3.5cm prox- 
imal to the bifurcation. A pathological dilatation of 
the infrarenal aorta was defined according to Sonesson 
et al. ~2 An aneurysm was defined as an aortic diameter 
_> 30 mm and/or  an isolated ilatation of the infrarenal 
aorta with the morphological appearance of an an- 
eurysm. From each registration a sequence of at least 
five representative consecutive diameter cycles was 
manually chosen, and the aortic diameters and the 
diameter changes calculated as means of the selected 
diameter cycles (Fig. 1). As both age and gender 
influence diameter and stiffness, 8'9 women and men 
were studied separately. As the aortic diameter is also 
related to body surface area, 12 the aortic diameters 
were corrected for the body surface area according to 
Du Bois and Berlington. ~3 
Lung function tests 
Spirometry, including measurement of vital capacity 
(VC) and forced expiratory volume in l s  (FEV0, was 
performed in 14 of the 17 women and in 16 of the 19 
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men with %-antitrypsin deficiency within 10 months 
of the measurements of aortic distensibility. Results 
are presented as a percentage of predicted values 
(based on studies of normal subjects in the same 
laboratory). 
Statistical analysis 
Analysis of non-linear regression with 95% confidence 
intervals (CI) for individual and mean prediction were 
used to define the normal ranges for stiffness and 
mean arterial blood pressure (MAP) in the control 
subjects according to age and gender. Analysis of 
covariance was then used to compare stiffness, MAP 
and the mean aortic diameters in women and men 
with ~l-antitrypsin deficiency with control subjects in 
corresponding sex and age ranges. Analysis of re- 
siduals was employed to test that the assumptions 
for the models were satisfied. The results were also 
expressed as a percentage of individually predicted 
values. Differences inaortic stiffness between ex-smok- 
ing/smoking patients and patients who had never 
smoked (using the percentage of predicted values) 
were statistically tested with a non-parametric test 
(Mann-Whitney U-test). Putative correlations between 
stiffness and VC and FEV~, respectively (using the 
percent of predicted values), were tested using linear 
regression, p<0.05 was taken as significant. Data are 
presented as the mean value + S.D., unless otherwise 
stated. 
Results 
Mean arterial blood pressures in the patients with ~- 
antitrypsin deficiency (Table 1) did not differ sig- 
nificantly from those in the control group of cor- 
responding age, either for women (92 _+ 7 vs. 92 _+9) or 
for men (99 _+ 8 vs. 96 _+ 11). The mean abdominal ortic 
diameter in men with %-antitrypsin deficiency was 
17.6_+2.2mm (range 14.3-22.0mm). The mean ab- 
dominal aortic diameter in women with ~l-antitrypsin 
deficiency was 14.7+1.6mm (range 12.3-17.95mm). 
No significant differences in the abdominal aortic dia- 
meter between patients with ~-antitrypsin deficiency 
and controls were seen when corrected for age, sex 
and body surface area (men p = 0.20, women p = 0.10). 
No patient with abdominal aortic aneurysm was 
detected. Figure 2(a) shows stiffness of the abdominal 
aorta in control men (mean_+95% CI) and in men 
with %-antitrypsin deficiency. Men with ~-antitrypsin 
deficiency showed significantly lower stiffness (16% 
lower, age-adjusted) in the distal abdominal aorta 
compared to controls (p=0.025). Figure 2(b) shows 
stiffness of the abdominal aorta in control women 
(mean_+95% CI) and in women with ~-antitrypsin 
deficiency. Women with ~-antitrypsin deficiency did 
not show any significant difference in aortic stiffness 
compared with control women (p=0.17). There was 
no significant correlation between aortic stiffness and 
VC or FEV~ expressed as a percentage of predicted 
values (r=0.34, p=0.06 and r=0.27, p=0.17, re- 
spectively). Two women (59 and 62 years old) and 
two men (61 and 79 years old) reported relatives with 
aortic aneurysm. 
Discussion 
Aneurysmal pathogenesis seems to be complex and 
heterogenous, and several investigators have tried to 
find a link between %-antitrypsin deficiency and the 
formation of abdominal aortic aneurysms. 5'6 There are 
several reasons for this. Reports of familial tendency 
for abdominal aortic aneurysms ~4'~5 and the male pre- 
dominance inmost cases 14 suggest a significant genetic 
component of the pathogenesis of some aneurysms. 
There are also clinical observations suggesting that 
abdominal aortic aneurysms may be a manifestation 
of a systemic abnormality, including the association 
between abdominal aortic aneurysm and peripheral 
aneurysms, 16 inguinal hernais, ~7 and arteriomegaly} 8 
There are also biochemical data supporting a systemic 
alteration in elastin metabolism in patients with ab- 
dominal aortic aneurysms} 9-21 
In 1990 Cohen et al. determined the ~-antitrypsin 
phenotypes in 47 patients with abdominal aortic an- 
eurysms} 2 The presence of the Z allele in this series 
was significantly higher than expected in the general 
population, suggesting a possible role of %-antitrypsin 
deficiency in the pathogenesis of abdominal aortic 
aneurysms in affected patients. On the other hand, St 
Jean et at., in a series of 65 patients with abdominal 
aortic aneurysm, did not demonstrate an increased 
incidence of %-antitrypsin deficiency. 23 
Further, Elzouki and Eriksson studied 30 con- 
secutive adults with known homozygos ~l-antitrypsin 
deficiency who underwent necropsy without finding 
any evidence for an increased risk of aneurysmal 
disease. 24
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Fig. 2. (a) Aortic stiffness in men with :xl-antitrypsin deficiency ( i ) .  Note the decreased stiffness (p=0.025). The solid lines represent 
mean, upper and lower 95% CI for the control men. (b) Aortic stiffness in women with ~l-antitrypsin deficiency ( i ) .  No significant 
difference in stiffness was found compared to control women (p = 0.17). The solid lines represent mean, upper and lower 95% CI for the 
control women. 
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The finding that there was no change at all in aortic 
diameter in the patients with severe ~l-antitrypsin 
deficiency compared to controls may argue against 
the putative relationship between abdominal aortic 
aneurysm and Czl-antitrypsin deficiency. There were, 
however, only about 10 men and eight women over 
50 years of age; the age group in which aneurysmal 
disease is most common. The material in the most 
interesting age group is thus small. Stiffness may be 
a more sensitive marker of early structural changes in 
the vessel wall. The changes in aortic stiffness in 
men with %-antitrypsin deficiency (Fig. 2a) were seen 
mainly in the ages over 50 years, i.e. the ages in which 
both the frequencies of emphysema and liver disease 
increase amongst these patients, but also when aortic 
aneurysms are found in the general population. How- 
ever, at this point it is not known whether changes in 
the mechanical properties of the aorta predict the 
formation of aneurysms. 
The finding of increased istensibility in the ab- 
dominal aorta is somewhat surprising. This contrasts 
with the theoretically expected stiffening due to de- 
creased elastin in the aortic wall. A tentative x- 
planation for this might be that the increased protease 
activity affects the collagen as well. The observation 
that patients with %-antitrypsin deficiency have an 
increased risk for panniculitis, characterised by de- 
struction of the fibrous septae of the subcutis, which 
are mainly composed of collagen, asmight support 
this notion. Another explanation might be a coupling 
between the protease/antiprotease sy tem in the blood 
and the metalloproteases of the arterial wall, 26 e.g. 
collagenase. 
Smoking has been recognised as a risk factor for 
abdominal aortic aneurysms, 27 and it is also known 
that smoking contributes to the accelerated course of 
lung disease in patients with %-antitrypsin deficiency. 
About 50% of both male and female patients in- 
vestigated were ex-smokers, having stopped smoking 
at least 15-20 years before the study. Only two men 
and two women were current smokers. The effects of 
smoking per se on arterial diameters and mechanical 
properties are not known at present, and this could 
be a confounding factor. No differences in stiffness 
could, however, be detected between ex-smoking/ 
smoking patients and patients who had never smoked. 
An interesting finding was the gender-related dif- 
ference in aortic distensibility in patients with %- 
antitrypsin deficiency. No difference in blood pressure, 
smoking habits or number or degree of lung disease 
could explain the selective decrease in aortic stiffness 
in men. However, it is known that abdominal aortic 
aneurysms are more common in men than in women, 
and the familial tendency for abdominal aortic an- 
eurysm is much more pronounced in men than in 
women. 14'15 Further, abdominal aortic aneurysms in 
men also tend to develop at a younger age than in 
women, and in this study there are very few women 
over the age of 60. There are also recent reports that 
emphysema develops at an earlier age in non-smoking 
men than in non-smoking women with <,~-antitrypsin 
deficiency. 28 
In conclusion, o significant difference in abdominal 
aortic diameter could be detected in patients with %- 
antitrypsin deficiency. However, the aortic dis- 
tensibility in men with Gtl-antitrypsin deficiency is 
altered. This may indicate early vessel wall ab- 
normality. The question of whether ~-antitrypsin de- 
ficiency is a pathogenetic factor that interacts with 
other genetic and environmental risk factors to cause 
aneurysmal disease needs further study. 
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